Combination Chemotherapy and Bevacizumab in Treating Patients With Advanced Neuroendocrine Tumors
- First Posted Date
- 2005-09-28
- Last Posted Date
- 2023-05-22
- Lead Sponsor
- University of California, San Francisco
- Target Recruit Count
- 36
- Registration Number
- NCT00227617
- Locations
- ๐บ๐ธ
Kaiser Permanente Medical Center - Vallejo, Vallejo, California, United States
๐บ๐ธUniveristy of California, San Francisco, San Francisco, California, United States
A Randomized, Placebo-controlled, Double-blind Clinical Trial of Curcuminoids in Oral Lichen Planus
- Conditions
- First Posted Date
- 2005-09-26
- Last Posted Date
- 2023-11-08
- Lead Sponsor
- University of California, San Francisco
- Registration Number
- NCT00226174
- Locations
- ๐บ๐ธ
University of California, San Francisco, California, United States
Specialized Cognitive-Behavioral Counseling Intervention to Reduce HIV Transmission Risk Behavior in HIV-Infected Men
- Conditions
- Interventions
- First Posted Date
- 2005-09-22
- Last Posted Date
- 2012-05-02
- Lead Sponsor
- University of California, San Francisco
- Target Recruit Count
- 488
- Registration Number
- NCT00218712
- Locations
- ๐บ๐ธ
SFDPH San Francisco City Clinic, San Francisco, California, United States
๐บ๐ธUCSF AIDS Health Project, San Francisco, California, United States
C-reactive Protein (CRP)-Guided Management Algorithm for Adults With Acute Cough
- Conditions
- First Posted Date
- 2005-09-22
- Last Posted Date
- 2011-05-23
- Lead Sponsor
- University of California, San Francisco
- Target Recruit Count
- 139
- Registration Number
- NCT00221351
- Locations
- ๐บ๐ธ
Veterans Affairs Medical Center, Kansas City, Missouri, United States
๐บ๐ธTruman Medical Center, Kansas City, Missouri, United States
Pre-HIV Test Counseling Intervention to Reduce HIV Infection Risk Behavior in Men Who Are Not HIV Infected
- Conditions
- First Posted Date
- 2005-09-22
- Last Posted Date
- 2013-08-05
- Lead Sponsor
- University of California, San Francisco
- Target Recruit Count
- 300
- Registration Number
- NCT00218699
- Locations
- ๐บ๐ธ
UCSF AIDS Health Project, San Francisco, California, United States
Clinical Trial of Gabapentin to Decrease Postoperative Delirium and Pain
- Conditions
- Interventions
- First Posted Date
- 2005-09-22
- Last Posted Date
- 2020-09-10
- Lead Sponsor
- University of California, San Francisco
- Target Recruit Count
- 750
- Registration Number
- NCT00221338
- Locations
- ๐บ๐ธ
University of California, San Francisco, San Francisco, California, United States
Trachoma Elimination Follow-up
- First Posted Date
- 2005-09-22
- Last Posted Date
- 2015-07-15
- Lead Sponsor
- University of California, San Francisco
- Target Recruit Count
- 20000
- Registration Number
- NCT00221364
- Locations
- ๐ช๐น
ORBIS-Ethiopia, Addis Ababa, Ethiopia
Intensive Intervention for Smokers - 6
- Conditions
- Interventions
- First Posted Date
- 2005-09-22
- Last Posted Date
- 2017-11-01
- Lead Sponsor
- University of California, San Francisco
- Target Recruit Count
- 162
- Registration Number
- NCT00217984
- Locations
- ๐บ๐ธ
VA Medical Center, San Francisco, California, United States
Fosamax Bone Loss Study: Alendronate to Prevent Bone Loss
- Conditions
- First Posted Date
- 2005-09-22
- Last Posted Date
- 2008-05-08
- Lead Sponsor
- University of California, San Francisco
- Target Recruit Count
- 48
- Registration Number
- NCT00221312
- Locations
- ๐บ๐ธ
University of California, San Francisco, San Francisco, California, United States
A Safety Study of Rituximab Plus MTX Injected Into the Cerebrospinal Fluid in the Treatment of Brain Lymphoma
- Conditions
- Interventions
- First Posted Date
- 2005-09-22
- Last Posted Date
- 2015-02-16
- Lead Sponsor
- University of California, San Francisco
- Target Recruit Count
- 14
- Registration Number
- NCT00221325
- Locations
- ๐บ๐ธ
Memorial Sloan-Kettering Cancer Center, New York, New York, United States
๐บ๐ธMD Anderson Cancer Center, Houston, Texas, United States
๐บ๐ธUniversity of California, San Francisco, San Francisco, California, United States